Zobrazeno 1 - 5
of 5
pro vyhledávání: '"M F, De Barros"'
Autor:
Antonio Celso Dantas Antonino, José Romualdo de Sousa Lima, Valmir Felix de Lima, Márcia A. M. F. de Barros, Alexandre Ricardo Pereira Schuler, Manuella Virginia Salgueiro Gondim
Publikováno v:
Revista Brasileira de Engenharia Agrícola e Ambiental v.22 n.7 2018
Revista Brasileira de Engenharia Agrícola e Ambiental
Universidade Federal de Campina Grande (UFCG)
instacron:UFCG
Revista Brasileira de Engenharia Agrícola e Ambiental-Agriambi, Vol 22, Iss 7, Pp 506-510
Revista Brasileira de Engenharia Agrícola e Ambiental, Volume: 22, Issue: 7, Pages: 506-510, Published: JUL 2018
Revista Brasileira de Engenharia Agrícola e Ambiental
Universidade Federal de Campina Grande (UFCG)
instacron:UFCG
Revista Brasileira de Engenharia Agrícola e Ambiental-Agriambi, Vol 22, Iss 7, Pp 506-510
Revista Brasileira de Engenharia Agrícola e Ambiental, Volume: 22, Issue: 7, Pages: 506-510, Published: JUL 2018
This study aimed to evaluate sulfamethoxazole sorption kinetics and isotherms using batch method. The experiment was carried out in typic eutrophic Regolithic Neosol (0-20 and 20-60 cm layers) located in the private reserve of the Riacho do Papagaio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dfad10b5c27dd6adb0c4dc69f74a691
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-43662018000700506
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-43662018000700506
Autor:
J. B. de Alencar, Andressa Higa Shinzato, José Machado, Ana Maria Sell, Jeane Eliete Laguila Visentainer, M. F. de Barros, Camila Rodrigues, Luciana Conci Macedo, C. B. Pelissari
Publikováno v:
Haemophilia. 21:e312-e316
The development of factor VIII (FVIII) inhibitor is the main complication of replacement therapy in patients with haemophilia A (HA). A ratio of 5-7% of individuals HA develops antibodies (inhibitors) against the FVIII infused during the treatment, t
Autor:
Marco Antônio Braga, F. C. de Melo, L. De Souza Hirle, Ana Maria Sell, M. F. de Barros, Juliana Curi Martinichen Herrero, José Machado, S. De Souza Schiller, Jeane Eliete Laguila Visentainer, C. B. Pelissari
Publikováno v:
Haemophilia. 18:e236-e240
Congenital haemophilia A is a chromosome-linked recessive disorder caused by the deficiency or reduction of factor VIII (FVIII) pro-coagulant activity. During treatment, some patients develop alloantibodies (FVIII inhibitors) that neutralize the acti
Autor:
D, Vianna, L L, Claro, A A, Mendes, A N, da Silva, D A, Bucci, P T, de Sá, V S, Rocha, J S, Pincer, I M F, de Barros, P R, Silva
Publikováno v:
European journal of cancer care. 22(3)
Through a quanti-qualitative study, we observed the effects of group expressive therapy (ET) sessions on patients' feelings and sense of well-being, as part of the Infusion of Life project. This project is part of a broader programme to improve integ
Autor:
M F, De Barros, J C M, Herrero, A M, Sell, F C, De Melo, M A, Braga, C B, Pelissari, J, Machado, S, De Souza Schiller, L, De Souza Hirle, J E L, Visentainer
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 18(3)
Congenital haemophilia A is a chromosome-linked recessive disorder caused by the deficiency or reduction of factor VIII (FVIII) pro-coagulant activity. During treatment, some patients develop alloantibodies (FVIII inhibitors) that neutralize the acti